TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8(+) T cell function.
TNFR2/CCR8 双特异性抗体通过消耗 Ti-Tregs 和增强效应 CD8(+) T 细胞功能来增强抗肿瘤活性
期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2025.2497171
Wang Ran, Xu Jiefang, Cheng Shipeng, Ling Zhiyang, Sonam Wangmo, Yang Jichao, Jin Fuquan, Wen Jing, Lu Xiao, Ma Liyan, Zhang Yaguang, Sun Xiaoyu, Yi Chunyan, Sun Bing
